CMIC
CMIC which established its CRO business in 1992, has supported such drug development-related activities as monitoring, data management, recruiting of test subjects and clinical test coordination as Japan's first CRO. Capitalizing on the long years of experience and know-how as a CRO, it engages mainly in PVC (Pharmaceutical Value Creator) activities including CMO and CSO, in support of the value chains of pharmaceutical companies. CMIC has a presence not only in Japan but in Asia (China, Korea, Singapore and Taiwan, China), Brazil and U.S.A, and engages in a wide range of activities.
Locations
- APAC
- Europe
- North America
- South America
Therapeutic Areas
- Bone / Osteoporosis
- Cardiovascular
- CNS
- Dental and Oral Health
- Dermatology
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Hepatology
- Immunology
- Infectious Diseases
- Inflammation
- Internal Diseases
- Metabolic Diseases
- Musculoskeletal
- Nephrology
- Neurology
- Nutrition and Health
- Obstetrics / Gynecology
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology/ENT (Ear/Nose/Throat)
- Pediatrics / Neonatology
- Pharmacology / Toxicology
- Podiatry
- Psychiatry
- Pulmonary
- Respiratory
- Rheumatology
- Sleep
- Surgery
- Thrombosis
- Urology
- Vaccines